US nonprofit GRID Alternatives launches new projects to provide renewable energy
As part of Illumina’s long-term commitment to sustainability, the Illumina Corporate Foundation made a one-year, $500,000 grant to support GRID Alternatives (Generating Renewable Ideas and Development Alternatives), a nonprofit committed to increasing access to renewable energy and training people for clean energy jobs.
Six startups from Indonesia, Ireland, Israel, South Africa, United Kingdom and the United States will receive seed investment and access to technology and expertise
SAN DIEGO, September 14, 2022 /3BL Media/ - Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it has invested in six genomics startups for the fifth global funding cycle of Illumina Accelerator in the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator is a world-class company creation engine focused on partnering with entrepreneurs to build breakthrough genomics startups. The program also announced today the October 1, 2022 application deadline for its next funding cycle.
Full agenda now available for September 28–October 1 event
SAN DIEGO, September 12, 2022 /3BL Media/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced the release of the full agenda for its inaugural Illumina Genomics Forum. The agenda for the four-day event can be seen here.
Presentations will include evidence on how genomic signatures and next-generation sequencing can improve the care of patients with cancer
SAN DIEGO, September 7, 2022 / 3BL Media / — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced the upcoming presentation of multiple oncology research abstracts at this year’s European Society of Medical Oncology (ESMO) annual meeting, September 9–13 in Paris. The abstracts underscore the value of next-generation sequencing (NGS) and Illumina’s oncology assays for cancer research and patient care.
Investment in new Shanghai-based facility will allow the company to better serve its customers and meet growing demand
SAN DIEGO, August 31, 2022 /3BL Media/ - Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the opening of its first manufacturing site in China. The new Shanghai-based facility enables localized production for Illumina's gene sequencing instruments and consumables and reflects the growing demand in the Chinese market for Illumina's systems and products.
CHARLOTTE, N.C., September 6, 2022 /3BL Media/ — Discovery Education and The Illumina Corporate Foundation today announced a new virtual experience – Genomics: Decoding the Language of Life Virtual Field Trip – to immerse students in grades 6-12 in the power of DNA. Presented by the Illumina Corporate Foundation and Discovery Education, this virtual field trip is part of DNA Decoded, a program designed to inspire students to unlock the power of genomics with ready-to-go, standards-aligned lessons and activities.